about
Growth factor induction of Cripto-1 shedding by glycosylphosphatidylinositol-phospholipase D and enhancement of endothelial cell migrationEctopic expression of Cripto-1 in transgenic mouse embryos causes hemorrhages, fatal cardiac defects and embryonic lethality.Novel Phenotypic Fluorescent Three-Dimensional Platforms for High-throughput Drug Screening and Personalized Chemotherapy.Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma.Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinomaSignificance and relationship between Cripto-1 and p-STAT3 expression in gastric cancer and precancerous lesions.ERK1/2-Akt1 crosstalk regulates arteriogenesis in mice and zebrafish.Tumorigenic factor CRIPTO-1 is immunolocalized in extravillous cytotrophoblast in placenta creta.Targeting the embryonic gene Cripto-1 in cancer and beyond.Genetic variants modulating CRIPTO serum levels identified by genome-wide association study in Cilento isolatesCRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activitiesCripto-1: a multifunctional modulator during embryogenesis and oncogenesis.Cyclic thrombospondin-1 mimetics: grafting of a thrombospondin sequence into circular disulfide-rich frameworks to inhibit endothelial cell migration.Cripto-1 enhances the canonical Wnt/β-catenin signaling pathway by binding to LRP5 and LRP6 co-receptors.Regulation of Cripto-1 signaling and biological activity by caveolin-1 in mammary epithelial cellsRegulation of human Cripto-1 expression by nuclear receptors and DNA promoter methylation in human embryonal and breast cancer cells.SCNH2 is a novel apelinergic family member acting as a potent mitogenic and chemotactic factor for both endothelial and epithelial cellsCripto-1 is required for hypoxia to induce cardiac differentiation of mouse embryonic stem cells.Age-Dependent Association between Protein Expression of the Embryonic Stem Cell Marker Cripto-1 and Survival of Glioblastoma Patients.Biological and Clinicopathological Significance of Cripto-1 Expression in the Progression of Human ESCC.Directed in vivo angiogenesis assay and the study of systemic neoangiogenesis in cancer.The multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition.Cripto-1: an extracellular protein - connecting the sequestered biological dots.Neuregulin-1β induces proliferation, survival and paracrine signaling in normal human cardiac ventricular fibroblasts.Cripto-1 expression in glioblastoma multiforme.Activation of a Nodal-independent signaling pathway by Cripto-1 mutants with impaired activation of a Nodal-dependent signaling pathwayGerm cell nuclear factor is a repressor of CRIPTO-1 and CRIPTO-3.Knockdown of Cripto-1 inhibits the proliferation, migration, invasion, and angiogenesis in prostate carcinoma cells.Serum Cripto-1 is a novel biomarker for non-small cell lung cancer diagnosis and prognosis.
P2860
Q24338408-17CFBF86-D062-415F-8F3D-6A44AFDE173AQ27339754-555AEF5C-CBD2-446B-B19E-A6D75E3E36F9Q30541176-35767DB6-A5F2-42B0-9DC3-C84152FF1050Q33500375-F150C514-294E-4D7B-A6E0-FEC9E8D3E19BQ33589032-5A3DDC88-64DB-4FA5-9A27-4D5A64DAB47FQ33629428-E3150ECD-4424-4501-A44E-21E17DEAD4BAQ33755332-998DF1E7-5F82-41FD-853A-1C25DF2BBDB5Q34073442-173B01A7-0254-43B1-A7F5-63CBD8E3E5ABQ34688767-0D9D74D6-FE91-4867-AFF5-FB169993E1BAQ35023500-2F306764-6D81-4A13-AB66-7FDA7F63B932Q35828490-5B4679CE-38B2-4130-AA0C-E7EF2F0AF0F4Q36241244-39A42CC9-3E1D-4E94-9491-F3F743CEC737Q36321375-92A1716D-9FDC-4CF3-9DF2-3A591B15A087Q36428279-738E00FB-878D-4088-8086-752DEAA5C611Q36559674-DA6BD221-F1EC-4163-8FF0-3C7DBE7651EDQ36612018-7692581E-D671-4417-8417-E9A8E2121E29Q37096061-6D788B5C-FB05-4790-9D0C-711DDBD3C368Q37413717-6E65F89D-A550-416D-864E-E08E64E42034Q37474393-C09ACC26-891B-47E4-94A2-68584C8F516DQ37694077-920D695B-B7DA-45B1-A6DF-EC2C15712F03Q37833570-7189EB5D-8626-439C-93E9-EE6AFB7997BAQ38242892-93692CE7-0BB5-452B-A2DD-0859F5BF8246Q38578005-228EDC89-72C2-4870-A495-697ABC7B4894Q38713492-869D0D79-2F11-4BDC-B540-BCDE948CFBCDQ39024553-13ED48A3-8C8A-4C73-B348-C9A3819D5595Q39915896-8796A0C7-CE54-4E8E-A97B-FE7737E9FEEAQ40235401-ADCD9A55-0348-4636-94AD-E85D0AF9D36FQ49866070-099EB70F-24B8-4499-B3D9-73C7F816D6C5Q51570919-25AC7489-E0AA-4621-8615-A1EFEDBE02F2
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Role of human cripto-1 in tumor angiogenesis.
@en
type
label
Role of human cripto-1 in tumor angiogenesis.
@en
prefLabel
Role of human cripto-1 in tumor angiogenesis.
@en
P2093
P2860
P356
P1476
Role of human cripto-1 in tumor angiogenesis.
@en
P2093
Aasia Rehman
Andreas Ebert
Barbara K Vonderhaar
Brenda Wallace-Jones
Caterina Bianco
Christian Wechselberger
Cindy Chang
David S Salomon
Erika Ginsburg
Giovanna Tosato
P2860
P304
P356
10.1093/JNCI/DJI011
P407
P577
2005-01-01T00:00:00Z